Scedosporium infection as a late complication after start of elexacaftor/tezacaftor/ivacaftor: two case reports. [PDF]
van Mourik P +6 more
europepmc +1 more source
Arterialized oxygen tension and unfavorable clinical outcomes in pediatric cystic fibrosis. [PDF]
Gaupmann R +8 more
europepmc +1 more source
Cystic Fibrosis and CFTR Modulators: The Impact on Bone Density, Muscle Mass and Strength in Children and Young Adolescents. [PDF]
Iordanidou K +6 more
europepmc +1 more source
Cutaneous Adverse Effects of Elexacaftor-Tezacaftor-Ivacaftor: A Single Center Cohort Study on Acne Severity in Adults With Cystic Fibrosis. [PDF]
Smith AD +5 more
europepmc +1 more source
CFTR acts as a potential therapeutic target for attention deficit-hyperactivity disorder. [PDF]
Li Q, Wang T, Li J, Lin X.
europepmc +1 more source
Is There a Role for Lumacaftor/Ivacaftor in Young Children with Cystic Fibrosis? [PDF]
Martin I, Grasemann H.
europepmc +1 more source
Reply to Martin and Grasemann: Is There a Role for Lumacaftor/Ivacaftor in Young Children with Cystic Fibrosis? [PDF]
Stahl M +3 more
europepmc +1 more source
Bioinformatics identification of key genes correlating NOD1 and Endoplasmic Reticulum stress in Hepatitis B virus-induced acute liver failure. [PDF]
Deng F +6 more
europepmc +1 more source
Hemoglobin Levels in Children Treated for Cystic Fibrosis with CFTR Modulators: A Single Center Retrospective Study. [PDF]
Tosco A +7 more
europepmc +1 more source

